GENE ONLINE|News &
Opinion
Blog

Asia-Pacific
Technology Apple
Biogen to Explore Apple’s Wearable Devices to Monitor Cognitive Health Markers
2021-01-13
COVID-19 Vaccine
Philippines Signs Second Vaccine Deal to Procure 30 Million Doses of Novavax’s Covovax
2021-01-12
COVID-19 Pandemic
COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic
2021-01-08
NDA
Daiichi Sankyo Files NDA for a New Oncolytic Virus in Japan
2021-01-07
COVID-19 Vaccine
Arcturus’ COVID Vaccine Moves to Phase 2 Trial in Singapore
2021-01-05
Trials & Approvals PARP Inhibitor
Lynparza Bags Multiple Approvals in Japan
2021-01-05
Funding Microbioreactor
Cytena Bioprocess Solutions Closes Pre-A series Funding, Accelerates Development in Microbioreactors
2020-12-29Partner
Manufacturing Drug Manufacturing
WuXi Biologics Acquires Bayer’s Drug Manufacturing Facility in Wuppertal
2020-12-25
China’s Hasten Biopharmaceutic Acquires Five Non-Core Assets from Japan’s Takeda
2020-12-24
Anti-tumor Drugs
Bayer’s New Anti-Tumor Drug BAY 2416964 Receives Approval for Clinical Use in China
2020-12-23
Startups
Taiwanese Startup, Micronbrane Aims to Improve Detection of Microbial Pathogens
2020-12-21Partner
R&D
NASH Drug Candidate, ASC42 Receives Fast Track Designation
2020-12-18
COVID-19 Vaccine
Fosun to Import 100 Million Doses of BioNTech’s COVID-19 Vaccine into China
2020-12-17
Gene Editing
Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
2020-12-17
COVID-19 Vaccine
Singapore Becomes First Country in Asia Pacific to Greenlight Pfizer/BioNTech’s COVID-19 Vaccine
2020-12-16
1 … 19 20 21 22 23 … 35
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top